ETFs & Funds
The Hep C Race Is Heating Up: Abbvie Vs. Gilead $
Add a reply...
Latest StockTalks »
people get ABBV breaking news and analysis by email alert.
Get email alerts on ABBV »
Get latest price
From other sites
Infinity Pharma At Risk Of AbbVie 'Walking Away'
at Benzinga (Jun 15, 2016)
Amgen's Biosimilar of AbbVie's Humira to Face FDA Panel
at Zacks.com (Jun 14, 2016)
BMO Shows Concern With AbbVie's Major Growth Drivers, Downgrades To Market Perform
at Benzinga (Jun 10, 2016)
Morgan Stanley: 4 Reasons We're Downgrading Abbvie
at Benzinga (Jun 8, 2016)
AbbVie at ASCO: Early-Stage Data on ABT-414 and Rova-T
at Zacks.com (Jun 6, 2016)